Ligand ID: DMO Drugbank ID: DB06243(Eflornithine) Indication:Eflornithine is indicated in the treatment of facial hirsutism (excessive hair growth). |
DrReposER ID / Desc. | Hit PDBID |
Hit Macromolecule |
Res. Matches |
View | Interface | RMSD | Seq. Identity (%) |
HETATM | Dock | |
---|---|---|---|---|---|---|---|---|---|---|
![]() | 2TOD_A_DMOA700_1 (PROTEIN (ORNITHINEDECARBOXYLASE)) | 2ghw | ANTI-SCFV ANTIBODY,80RSPIKE GLYCOPROTEIN (Homosapiens;SARSr-CoV) | 4 / 6 | TYR D 181ASP D 105ASP D 99TYR C 491 | 1.70A | 20.52 | NoneNoneNone CL C 20 ( 3.8A) | ||
![]() | 2TOD_A_DMOA700_1 (PROTEIN (ORNITHINEDECARBOXYLASE)) | 2ghw | SPIKE GLYCOPROTEIN (SARSr-CoV) | 4 / 6 | TYR C 356CYH C 366PHE C 364TYR C 352 | 1.79A | 20.14 | None | ||
![]() | 2TOD_A_DMOA700_1 (PROTEIN (ORNITHINEDECARBOXYLASE)) | 2ozk | URIDYLATE-SPECIFICENDORIBONUCLEASE (SARSr-CoV) | 4 / 6 | TYR C 225ASP C 212PHE C 221ASP C 300 | 1.65A | 22.10 | None | ||
![]() | 2TOD_A_DMOA700_1 (PROTEIN (ORNITHINEDECARBOXYLASE)) | 2rhb | URIDYLATE-SPECIFICENDORIBONUCLEASE (SARSr-CoV) | 4 / 6 | TYR C 225ASP C 212PHE C 221ASP C 300 | 1.63A | 22.27 | None | ||
![]() | 2TOD_B_DMOB700_1 (PROTEIN (ORNITHINEDECARBOXYLASE)) | 2w2g | NSP3 (SARSr-CoV) | 4 / 5 | ASP B 481TYR B 483CYH B 507PHE B 511 | 1.28A | 20.41 | None | ||
![]() | 2TOD_A_DMOA700_1 (PROTEIN (ORNITHINEDECARBOXYLASE)) | 2w2g | NSP3 (SARSr-CoV) | 4 / 6 | CYH B 507PHE B 511ASP B 481TYR B 483 | 1.28A | 20.41 | None | ||
![]() | 3GN0_A_DMOA551_1 (ARGINASE-1) | 3iwm | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 9 | HIS B 41ASN B 28SER B 144HIS B 163GLY B 146 | 1.78A | 23.48 | PJE F 5 (-4.8A)NonePJE F 5 ( 4.6A)PJE F 5 (-4.0A)None | ||
![]() | 2TOD_A_DMOA700_1 (PROTEIN (ORNITHINEDECARBOXYLASE)) | 5c8s | GUANINE-N7METHYLTRANSFERASENSP10 (SARSr-CoV) | 4 / 6 | TYR D 69ASP C 29PHE C 16ASP C 22 | 1.17A | 21.85 | None | ||
![]() | 2TOD_A_DMOA700_1 (PROTEIN (ORNITHINEDECARBOXYLASE)) | 5c8u | GUANINE-N7METHYLTRANSFERASENSP10 (SARSr-CoV) | 4 / 6 | TYR B 69ASP A 29PHE A 16ASP A 22 | 1.18A | 21.45 | None | ||
![]() | 2TOD_A_DMOA700_1 (PROTEIN (ORNITHINEDECARBOXYLASE)) | 5nfy | POLYPROTEIN 1AB (SARS-COVFrankfurt1) | 4 / 6 | TYR D 69ASP O 29PHE O 16ASP O 22 | 1.15A | 22.49 | None | ||
![]() | 2TOD_A_DMOA700_1 (PROTEIN (ORNITHINEDECARBOXYLASE)) | 5x4s | SPIKE GLYCOPROTEIN (SARSr-CoV) | 4 / 6 | TYR A 41ASP A 57PHE A 59ASP A 44 | 1.73A | 21.86 | None | ||
![]() | 2TOD_A_DMOA700_1 (PROTEIN (ORNITHINEDECARBOXYLASE)) | 5x58 | SPIKE GLYCOPROTEIN (SARS-COVBJ01) | 4 / 6 | TYR B 41ASP B 57PHE B 59ASP B 44 | 1.56A | 16.25 | None | ||
![]() | 2TOD_A_DMOA700_1 (PROTEIN (ORNITHINEDECARBOXYLASE)) | 6acc | SPIKE GLYCOPROTEIN (SARSr-CoV) | 4 / 6 | TYR A 41ASP A 57PHE A 59ASP A 44 | 1.66A | 15.76 | None | ||
![]() | 3GN0_A_DMOA551_1 (ARGINASE-1) | 6acd | SPIKE GLYCOPROTEIN (SARSr-CoV) | 5 / 9 | ASP A 296ASN A 589GLY A 587GLU A 294THR A 925 | 1.76A | 14.26 | None | ||
![]() | 2TOD_A_DMOA700_1 (PROTEIN (ORNITHINEDECARBOXYLASE)) | 6crv | SPIKEGLYCOPROTEIN,FIBRITIN (SARSr-CoV) | 4 / 6 | TYR C 41ASP C 57PHE C 59ASP C 44 | 1.72A | 16.94 | None | ||
![]() | 2TOD_A_DMOA700_1 (PROTEIN (ORNITHINEDECARBOXYLASE)) | 6crw | SPIKEGLYCOPROTEIN,FIBRITIN (SARSr-CoV) | 4 / 6 | TYR A 41ASP A 57PHE A 59ASP A 44 | 1.66A | 16.94 | None | ||
![]() | 2TOD_B_DMOB700_1 (PROTEIN (ORNITHINEDECARBOXYLASE)) | 6m1d | SODIUM-DEPENDENTNEUTRAL AMINO ACIDTRANSPORTER B(0)AT1 (Homosapiens) | 4 / 5 | TYR C 41CYH C 299ASP C 302PHE C 90 | 1.65A | 21.90 | None | ||
![]() | 2TOD_A_DMOA700_1 (PROTEIN (ORNITHINEDECARBOXYLASE)) | 6m1d | SODIUM-DEPENDENTNEUTRAL AMINO ACIDTRANSPORTER B(0)AT1 (Homosapiens) | 4 / 6 | CYH C 299ASP C 302PHE C 90TYR C 41 | 1.65A | 21.90 | None | ||
![]() | 2TOD_A_DMOA700_1 (PROTEIN (ORNITHINEDECARBOXYLASE)) | 6nus | NSP12 (SARSr-CoV) | 4 / 6 | CYH A 139ASP A 135PHE A 134TYR A 163 | 1.47A | 19.52 | None | ||
![]() | 2TOD_B_DMOB700_1 (PROTEIN (ORNITHINEDECARBOXYLASE)) | 6nus | NSP12 (SARSr-CoV) | 4 / 5 | TYR A 163CYH A 139ASP A 135PHE A 134 | 1.45A | 19.52 | None |